151 related articles for article (PubMed ID: 12112451)
21. Stress induced changes in cortical and hypothalamic c-fos expression are altered in fragile X mutant mice.
Lauterborn JC
Brain Res Mol Brain Res; 2004 Nov; 131(1-2):101-9. PubMed ID: 15530658
[TBL] [Abstract][Full Text] [Related]
22. Enhanced markers of oxidative stress, altered antioxidants and NADPH-oxidase activation in brains from Fragile X mental retardation 1-deficient mice, a pathological model for Fragile X syndrome.
el Bekay R; Romero-Zerbo Y; Decara J; Sanchez-Salido L; Del Arco-Herrera I; Rodríguez-de Fonseca F; de Diego-Otero Y
Eur J Neurosci; 2007 Dec; 26(11):3169-80. PubMed ID: 18005058
[TBL] [Abstract][Full Text] [Related]
23. Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation.
Qin M; Kang J; Smith CB
Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15758-63. PubMed ID: 12427968
[TBL] [Abstract][Full Text] [Related]
24. Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome.
Spencer CM; Alekseyenko O; Serysheva E; Yuva-Paylor LA; Paylor R
Genes Brain Behav; 2005 Oct; 4(7):420-30. PubMed ID: 16176388
[TBL] [Abstract][Full Text] [Related]
25. Audiogenic seizure susceptibility is reduced in fragile X knockout mice after introduction of FMR1 transgenes.
Musumeci SA; Calabrese G; Bonaccorso CM; D'Antoni S; Brouwer JR; Bakker CE; Elia M; Ferri R; Nelson DL; Oostra BA; Catania MV
Exp Neurol; 2007 Jan; 203(1):233-40. PubMed ID: 17007840
[TBL] [Abstract][Full Text] [Related]
26. Altered expression of Autism-associated genes in the brain of Fragile X mouse model.
Zhang A; Shen CH; Ma SY; Ke Y; El Idrissi A
Biochem Biophys Res Commun; 2009 Feb; 379(4):920-3. PubMed ID: 19138667
[TBL] [Abstract][Full Text] [Related]
27. Genotype, molecular phenotype, and cognitive phenotype: correlations in fragile X syndrome.
Kaufmann WE; Abrams MT; Chen W; Reiss AL
Am J Med Genet; 1999 Apr; 83(4):286-95. PubMed ID: 10208163
[TBL] [Abstract][Full Text] [Related]
28. Developmental expression of FMRP in the astrocyte lineage: implications for fragile X syndrome.
Pacey LK; Doering LC
Glia; 2007 Nov; 55(15):1601-9. PubMed ID: 17823967
[TBL] [Abstract][Full Text] [Related]
29. Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice.
Frankland PW; Wang Y; Rosner B; Shimizu T; Balleine BW; Dykens EM; Ornitz EM; Silva AJ
Mol Psychiatry; 2004 Apr; 9(4):417-25. PubMed ID: 14981523
[TBL] [Abstract][Full Text] [Related]
30. Fragile X mental retardation: misregulation of protein synthesis in the developing brain?
Feng Y
Microsc Res Tech; 2002 May; 57(3):145-7. PubMed ID: 12112449
[TBL] [Abstract][Full Text] [Related]
31. Long-term potentiation in the hippocampus of fragile X knockout mice.
Godfraind JM; Reyniers E; De Boulle K; D'Hooge R; De Deyn PP; Bakker CE; Oostra BA; Kooy RF; Willems PJ
Am J Med Genet; 1996 Aug; 64(2):246-51. PubMed ID: 8844057
[TBL] [Abstract][Full Text] [Related]
32. Rgs4 mRNA expression is decreased in the brain of Fmr1 knockout mouse.
Tervonen T; Akerman K; Oostra BA; Castrén M
Brain Res Mol Brain Res; 2005 Jan; 133(1):162-5. PubMed ID: 15661377
[TBL] [Abstract][Full Text] [Related]
33. Social behavior phenotypes in fragile X syndrome, autism, and the Fmr1 knockout mouse: theoretical comment on McNaughton et al. (2008).
Brodkin ES
Behav Neurosci; 2008 Apr; 122(2):483-9. PubMed ID: 18410188
[TBL] [Abstract][Full Text] [Related]
34. Olfactory bulb mitral cell dendritic pruning abnormalities in a mouse model of the Fragile-X mental retardation syndrome: further support for FMRP's involvement in dendritic development.
Galvez R; Smith RL; Greenough WT
Brain Res Dev Brain Res; 2005 Jun; 157(2):214-6. PubMed ID: 15878626
[TBL] [Abstract][Full Text] [Related]
35. FMRP expression as a potential prognostic indicator in fragile X syndrome.
Tassone F; Hagerman RJ; Iklé DN; Dyer PN; Lampe M; Willemsen R; Oostra BA; Taylor AK
Am J Med Genet; 1999 May; 84(3):250-61. PubMed ID: 10331602
[TBL] [Abstract][Full Text] [Related]
36. Immunocytochemical and biochemical characterization of FMRP, FXR1P, and FXR2P in the mouse.
Bakker CE; de Diego Otero Y; Bontekoe C; Raghoe P; Luteijn T; Hoogeveen AT; Oostra BA; Willemsen R
Exp Cell Res; 2000 Jul; 258(1):162-70. PubMed ID: 10912798
[TBL] [Abstract][Full Text] [Related]
37. Reduced FMR1 mRNA translation efficiency in fragile X patients with premutations.
Primerano B; Tassone F; Hagerman RJ; Hagerman P; Amaldi F; Bagni C
RNA; 2002 Dec; 8(12):1482-8. PubMed ID: 12515381
[TBL] [Abstract][Full Text] [Related]
38. FMRP detection assay for the diagnosis of the fragile X syndrome.
Willemsen R; Oostra BA
Am J Med Genet; 2000; 97(3):183-8. PubMed ID: 11449486
[TBL] [Abstract][Full Text] [Related]
39. A fragile balance: FMR1 expression levels.
Oostra BA; Willemsen R
Hum Mol Genet; 2003 Oct; 12 Spec No 2():R249-57. PubMed ID: 12952862
[TBL] [Abstract][Full Text] [Related]
40. Prospects for gene therapy in the fragile X syndrome.
Rattazzi MC; LaFauci G; Brown WT
Ment Retard Dev Disabil Res Rev; 2004; 10(1):75-81. PubMed ID: 14994292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
